Published annually since 1972, the Historic Documents series has made primary source research easy by presenting excerpts from documents on the important events of each year for the United States and the World. Each volume pairs 60 to 70 original background narratives with over 100 documents to chronicle the major events. Various records may include: • official reports • surveys • speeches from leaders and opinion makers • court cases • legislation • testimony • and much more Historic Documents is renowned for the well-written and informative background, history, and context it provides for each document. Organized chronologically, each volume covers the same wide range of topics: • business • the economy and labor • energy, environment, science, technology, and transportation • government and politics • health and social services • international affairs • national security and terrorism • rights and justice Each volume begins with an insightful essay that sets the year’s events in context, and each document or group of documents include: • a comprehensive introduction • background information on the event • full-source citations • easy access to material • detailed and thematic table of contents • references to related coverage • documents from the last ten editions of the series
Chapter : CDC and FDA React to Vaping-Linked Lung Illnesses : August 30 and September 11, 2019
CDC and FDA React to Vaping-Linked Lung Illnesses : August 30 and September 11, 2019
Though traditional cigarette smoking among youth and young adults has been in decline for decades, in recent years, public health officials have reported an uptick in electronic cigarette use. In 2019, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) raised alarm about the growing number of young people arriving in emergency rooms and doctors’ offices with severe respiratory distress brought on by the use of e-cigarette products. While federal agencies struggled to pinpoint the exact ingredient in e-cigarettes causing lung illnesses and even death, the White House partnered with the FDA ...